Rossari Biotech Profit & Loss Annual

BSE: 543213 | NSE: ROSSARI | ISIN: INE02A801020 | Sector: Chemical Manufacturing
714.90 +6.35 (0.90%)Updated : 16 May 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Revenue 2,080.291,830.561,655.881,482.97
Total Revenue 2,080.291,830.561,655.881,482.97
Costof Revenue Total 1,433.301,293.531,171.311,105.04
Gross Profit 647.00537.03484.57377.93
Selling/ General/ Admin Expenses Total 132.33282.44241.16179.27
Depreciation/ Amortization 67.0760.3962.9348.06
Other Operating Expenses Total 249.5811.5220.3915.17
Total Operating Expense 1,882.281,647.871,495.791,342.66
Operating Income 198.01182.69160.09140.31
Interest Inc( Exp) Net- Non- Op Total -16.832.820.596.82
Other Net 4.01-9.77-16.74-11.50
Net Income Before Taxes 185.19177.62144.22136.28
Provisionfor Income Taxes 48.8146.9336.9638.58
Net Income After Taxes 136.38130.69107.2697.70
Minority Interest 0.000.000.00-0.02
Net Income Before Extra Items 136.38130.69107.2697.67
Net Income 136.38130.69107.2697.67
Income Availableto Com Excl Extra Ord 136.38130.69107.2697.67
Income Availableto Com Incl Extra Ord 136.38130.69107.2697.67
Diluted Net Income 136.38130.69107.2697.67
Diluted Weighted Average Shares 5.545.535.545.52
Diluted EPS Excluding Extra Ord Items 24.6323.6219.3817.70
DPS- Common Stock Primary Issue 0.500.500.500.50
Diluted Normalized EPS 24.6323.3719.3416.99
period Length 12.0012.0012.0012.00
period Type ----
Gain( Loss)on Saleof Assets -1.880.280.64
Unusual Expense( Income) --0.00-4.88
*All figures in crores except per share values
Recommended For You
Trending Stocks
735.00+6.95(0.95%)
345.10+3.15(0.92%)
11,966.20+77.15(0.65%)
1,819.00-47.80 (-2.56%)
763.40-16.90 (-2.17%)